Related references
Note: Only part of the references are listed.Advances in molecular classification and precision oncology in hepatocellular carcinoma
Sandra Rebouissou et al.
JOURNAL OF HEPATOLOGY (2020)
Genome sequencing analysis of liver cancer for precision medicine
Hidewaki Nakagawa et al.
SEMINARS IN CANCER BIOLOGY (2019)
A miR-194/PTBP1/CCND3 axis regulates tumor growth in human hepatocellular carcinoma
Hoin Kang et al.
JOURNAL OF PATHOLOGY (2019)
Signalling involving MET and FAK supports cell division independent of the activity of the cell cycle-regulating CDK4/6 kinases
Chi Zhang et al.
ONCOGENE (2019)
Characterisation of class VI TRIM RING domains: linking RING activity to C-terminal domain identity
Rebecca V. Stevens et al.
LIFE SCIENCE ALLIANCE (2019)
UBE2S enhances the ubiquitination of p53 and exerts oncogenic activities in hepatocellular carcinoma
Ying-Hua Pan et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2018)
Prognostic value of ubiquitin-conjugating enzyme E2 S overexpression in hepatocellular carcinoma
Yili Ma et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES (2018)
Ube2s stabilizes β-Catenin through K11-linked polyubiquitination to promote mesendoderm specification and colorectal cancer development
Zhaoyan Li et al.
CELL DEATH & DISEASE (2018)
Recent advances in small molecule based cancer immunotherapy
Binbin Cheng et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2018)
A patent review of the ubiquitin ligase system: 2015-2018
Xin Li et al.
EXPERT OPINION ON THERAPEUTIC PATENTS (2018)
Looking beyond drivers and passengers in cancer genome sequencing data
S. De et al.
ANNALS OF ONCOLOGY (2017)
Therapeutic Potential of Small Molecule Inhibitors
Nimmish Khera et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2017)
The biology of Hepatocellular carcinoma: implications for genomic and immune therapies
Galina Khemlina et al.
MOLECULAR CANCER (2017)
RNF8-and Ube2S-Dependent Ubiquitin Lysine 11-Linkage Modification in Response to DNA Damage
Atanu Paul et al.
MOLECULAR CELL (2017)
A three-caller pipeline for variant analysis of cancer whole-exome sequencing data
Ze-Kun Liu et al.
MOLECULAR MEDICINE REPORTS (2017)
Bioinformatics analysis of the prognostic value of Tripartite Motif 28 in breast cancer
Ling Hao et al.
ONCOLOGY LETTERS (2017)
Dietary flavonoids, luteolin and quercetin, inhibit invasion of cervical cancer by reduction of UBE2S through epithelial-mesenchymal transition signaling
Tsung-Han Lin et al.
FOOD & FUNCTION (2017)
The complexity of TRIM28 contribution to cancer
Patrycja Czerwinska et al.
JOURNAL OF BIOMEDICAL SCIENCE (2017)
UBE2S associated with OSCC proliferation by promotion of P21 degradation via the ubiquitin-proteasome system
Shusaku Yoshimura et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2017)
Structural determinants of TRIM protein function
Diego Esposito et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2017)
Ube2s regulates Sox2 stability and mouse ES cell maintenance
J. Wang et al.
CELL DEATH AND DIFFERENTIATION (2016)
TRIM28 as an independent prognostic marker plays critical roles in glioma progression
Zeng-Xin Qi et al.
JOURNAL OF NEURO-ONCOLOGY (2016)
Hippocalcin-Like 1 Suppresses Hepatocellular Carcinoma Progression by Promoting p21Waf/Cip1 Stabilization by Activating the ERK1/2-MAPK Pathway
Yonglong Zhang et al.
HEPATOLOGY (2016)
Degradation of AMPK by a Cancer-Specific Ubiquitin Ligase
Carlos T. Pineda et al.
CELL (2015)
Exome sequencing of hepatocellular carcinomas identifies new mutational signatures and potential therapeutic targets
Kornelius Schulze et al.
NATURE GENETICS (2015)
Enhanced Protein Degradation by Branched Ubiquitin Chains
Hermann-Josef Meyer et al.
CELL (2014)
Mechanism of Polyubiquitination by Human Anaphase-Promoting Complex: RING Repurposing for Ubiquitin Chain Assembly
Nicholas G. Brown et al.
MOLECULAR CELL (2014)
Trim28 Contributes to EMT via Regulation of E-Cadherin and N-Cadherin in Lung Cancer Cell Lines
Lu Chen et al.
PLOS ONE (2014)
Integrative genomics viewer
James T. Robinson et al.
NATURE BIOTECHNOLOGY (2011)
KAP1 Is Associated With Peritoneal Carcinomatosis in Gastric Cancer
Takeshi Yokoe et al.
ANNALS OF SURGICAL ONCOLOGY (2010)
A Nucleus-based Quality Control Mechanism for Cytosolic Proteins
Rupali Prasad et al.
MOLECULAR BIOLOGY OF THE CELL (2010)
ZNF274 Recruits the Histone Methyltransferase SETDB1 to the 3′ Ends of ZNF Genes
Seth Frietze et al.
PLOS ONE (2010)
RING Domain E3 Ubiquitin Ligases
Raymond J. Deshaies et al.
ANNUAL REVIEW OF BIOCHEMISTRY (2009)
UBE2S elongates ubiquitin chains on APC/C substrates to promote mitotic exit
Mathew J. Garnett et al.
NATURE CELL BIOLOGY (2009)
Building ubiquitin chains: E2 enzymes at work
Yihong Ye et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2009)
Ubiquitin-like protein activation by E1 enzymes: the apex for downstream signalling pathways
Brenda A. Schulman et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2009)
Identification of a physiological E2 module for the human anaphase-promoting complex
Adam Williamson et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
The ubiquitin-conjugating enzyme E2-EPF is overexpressed in primary breast cancer and modulates sensitivity to topoisomerase II inhibition
Donato Tedesco et al.
NEOPLASIA (2007)
E2-EPF UCP targets pVHL for degradation and associates with tumor growth and metastasis
Cho-Rok Jung et al.
NATURE MEDICINE (2006)
A proteomics approach to understanding protein ubiquitination
JM Peng et al.
NATURE BIOTECHNOLOGY (2003)
Share Paper
